Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Cantor Fitzgerald Starts Intuitive Surgical (ISRG) at Neutral
-
Cantor Fitzgerald Starts Integra LifeSciences (IART) at Overweight
-
Cantor Fitzgerald Starts Hill-Rom Holdings (HRC) at Neutral
-
Cantor Fitzgerald Starts Baxter International (BAX) at Overweight
-
Cantor Fitzgerald Starts AxoGen, Inc. (AXGN) at Overweight
-
Pre-Open Movers 06/29: (STZ) (WATT) (WBA) Higher; (FRED) (RAD) (PIR) Lower (more...)
-
After-Hours Movers 06/28: (GEMP) (PRGS) (NXTD) Higher; (PIR) (BLCM) (DOC) Lower (more...)
-
Valeant Pharmaceuticals (VRX) PT Raised to $23 at Cantor Fitzgerald
-
Chembio Diagnostics (CEMI) Diagnostics Announces $21.2M At-The-Market Program
-
Chembio Diagnostics Announces At-The-Market Program
-
Justin Short Joins Hunt Mortgage Group as Managing Director
-
Pre-Open Movers 06/27: (CGIX) (ARNA) (DRI) Higher; (ALDR) (FNJN) (NEOS) Lower (more...)
-
Neos Therapeutics (NEOS) Prices $32.4M Common Stock Offering
-
Neos Therapeutics Announces Pricing of Underwritten Public Offering of $32.4 Million of Common Stock
-
Rambler Metals & Mining PLC: Exploration Update
-
After-Hours Stock Movers 06/26: (AMRN) (ESPR) (RAD) Higher; (FNJN) (NEOS) (BLUE) Lower (more...)
-
UPDATE: Cantor Fitzgerald Assumes Amarin Corporation (AMRN) at Overweight
-
Neos Therapeutics (NEOS) Plans $30M Common Stock Offering
-
Neos Therapeutics Announces Proposed Offering of Common Stock
-
Cantor Fitzgerald Assumes Cidara Therapeutics (CDTX) at Overweight, Sees Underappreciated Sales Potential
-
bluebird bio (BLUE) PT Raised to $39 at Cantor Fitzgerald, Keeps 'Underweight' Rating
-
The Trade Desk (TTD) PT Raised to $60 at Cantor Fitzgerald; 'Extending DCF-Based Model to Seven Years'
-
Cantor Fitzgerald Assumes Nabriva Therapeutics AG (NBRV) at Overweight
-
Teva (TEVA) Remanezumab Can Lead in Potential $8-$10B CGRP Market
-
Pre-Open Movers 06/22: (ORCL) (HAIN) (SPLS) (AA) Higher; (ENSC) (KMDA) (SCS) Lower (more...)
-
Spring Bank Pharmaceuticals (SBPH) Prices 2.88M Common Stock Offering at $13/Share
-
Spring Bank Pharmaceuticals Prices $37.5 Million Public Offering of Common Stock
-
UPDATE: Cantor Fitzgerald Starts Dermira (DERM) at Overweight
-
After-Hours Stock Movers 06/21: (ORCL) (PRTK) (NRZ) Higher; (SCS) (JCAP) (THMC) Lower (more...)
-
Cantor Fitzgerald Assumes Paratek Pharmaceuticals (PRTK) at Overweight
-
Spring Bank Pharmaceuticals (SBPH) Announces Proposed Common Share Offering
-
Spring Bank Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
MCAP LLC Expands ADR & Foreign Ordinary Market Making Operation
-
Reminder: Capital Link's 4th Annual Dissect ETFs Forum
-
Centene (CNC) PT Raised to $90 at Cantor Fitzgerald, "Growth Strategy Remains in Place"
-
Pre-Open Movers 06/16: (CLSN) (HOS) (FNSR) Higher; Whole Foods/Amazon News Impacts All Grocers (more...)
-
Valeant Pharma (VRX) Set to Open Positive Following 'Overweight' Rating
-
After-Hours Stock Movers 06/15: (HOS) (FNSR) (HZNP) Higher; (BAH) Lower (more...)
-
UPDATE: Cantor Fitzgerald Starts Shire (SHPG) at Overweight
-
UPDATE: Cantor Fitzgerald Starts Zoetis Inc. (ZTS) at Overweight, Sees Upside To EPS Estimates From M&A Among Other Things
-
UPDATE: Cantor Fitzgerald Starts Valeant Pharmaceuticals (VRX) at Overweight
-
UPDATE: Cantor Fitzgerald Starts Teva Pharma (TEVA) at Neutral, "We like Teva’s stock"
-
UPDATE: Cantor Fitzgerald Starts Theravance Biopharma (TBPH) at Overweight
-
UPDATE: Cantor Fitzgerald Starts Mylan (MYL) at Neutral
-
UPDATE: Cantor Fitzgerald Starts Mallinckrodt plc (MNK) at Overweight
-
UPDATE: Cantor Fitzgerald Starts Impax Laboratories (IPXL) at Overweight, Sees EPS Upside From Stratgeic M&A Deals
-
UPDATE: Cantor Fitzgerald Starts Horizon Pharma (HZNP) at Overweight
-
UPDATE: Cantor Fitzgerald Starts Endo International plc (ENDP) at Neutral
-
UPDATE: Cantor Fitzgerald Starts Allergen (AGN) at Neutral
-
UPDATE: Cantor Fitzgerald Starts Aclaris Therapeutis (ACRS) at Overweight

